Effer-KOrange (Nomax Inc.)
Welcome to the PulseAid listing for the Effer-K drug offered from Nomax Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Nomax Inc. |
NON-PROPRIETARY NAME: | POTASSIUM BICARBONATE |
SUBSTANCE NAME: | POTASSIUM BICARBONATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, EFFERVESCENT |
MARKETING CATEGORY NAME: | UNAPPROVED DRUG OTHER |
START MARKETING DATE: | 2013-01-30 |
END MARKETING DATE: | 0000-00-00 |
Effer-K Orange HUMAN PRESCRIPTION DRUG Details:
Item Description | Effer-K Orange from Nomax Inc. |
LABELER NAME: | Nomax Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 977.5(mg/1) |
START MARKETING DATE: | 2013-01-30 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 51801-001_63ede6be-645a-4386-a575-47a4d5469a54 |
PRODUCT NDC: | 51801-001 |
APPLICATION NUMBER: | |
Other POTASSIUM BICARBONATE Pharmaceutical Manufacturers / Labelers: